<DOC>
	<DOC>NCT02896361</DOC>
	<brief_summary>This purpose of this study is to evaluate the therapeutic efficacy of burst microdosing stimulation paradigms in patients with chronic pain.</brief_summary>
	<brief_title>Burst Optimized Stimulation Study</brief_title>
	<detailed_description>This is a prospective, multicenter, randomized, double-blinded crossover study designed to compare conventional burst stimulation parameters to two different burst microdosing paradigms. Subjects will be randomized 1:1:1 to one of the three groups. Each group will evaluate all 3 stimulation paradigms in different order.</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<criteria>Subject has been implanted with a commercially available SJM spinal cord stimulator for controlling chronic intractable pain associated with back and/or leg pain; Subject has been exclusively using burst stimulation for at least three months; Subject is 18 years of age or older; Subject's painrelated medication regimen was stable in the 4 weeks prior to the screening evaluation; Subject agrees not to add or increase painrelated medication from enrollment through the study duration; Subject is willing to cooperate with the study requirements including compliance with the regimen and completion of all office visits; Subject is currently participating in a clinical investigation study that includes an active treatment arm; Subject is currently receiving, applying or considering seeking workers compensation, or is involved in disability litigation; Subject has a non SJM neuromodulation device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>